Liquidia Corporation (LQDA) stock analysis

LQDA · Liquidia Corporation

Latest recorded price: USD 56.37

Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic

Fiscal 2025 figures: revenue growth 115.0%, free cash flow margin -25.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare